Single shot Johnson and Johnson Coronavirus Vaccine approved in Britain: Single shot Johnson and Johnson Coronavirus Vaccine approved in UK
Regulators in Britain on Friday approved another anti-coronavirus vaccine for use in the country. The Medicines and Healthcare Products Regulatory Agency stated that the single-dose vaccine prepared by Johnson & Johnson met the ‘expected standards of safety, quality and effectiveness’.
After the approval of the use of this vaccine, the number of such vaccines in the country has increased to four, which have been approved. Earlier two-dose vaccines developed by Pfizer / Bioentech, AstraZeneca and the University of Oxford and Moderna were approved.
The regulator said the vaccine developed by Johnson & Johnson’s subsidiary Jensen has been found to be 67 percent overall effective in preventing COVID-19 infection and 85 percent in preventing serious illness or hospitalization. It can be stored at a temperature of 2 to 8 °C. This makes the vaccine “ideal for distribution to care units and other locations,” the regulator said.
Britain has rapidly introduced vaccines since December. About 58 percent of the population has been given at least one dose and about 35 percent have received two. The UK has seen a slight increase in recent cases of new types of corona vias, which have been considered more infectious than earlier types of the virus.
Second Dose Different Vaccine: If a different vaccine is accidentally administered in the second dose, do not panic, Dr. Paul explained the whole thing.
#Single #shot #Johnson #Johnson #Coronavirus #Vaccine #approved #Britain #Single #shot #Johnson #Johnson #Coronavirus #Vaccine #approved